Evidence map›Paper›PMID 27040559›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2016

Clinical and morphological aspects of adenocarcinomas of the intestinal type in the inner nose: a retrospective multicenter analysis.

K Donhuijsen, I Kollecker, P Petersen, N Gaßler, J Wolf, H-G Schroeder

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

K DonhuijsenInstitute of Pathology, Academic Hospital Braunschweig, Braunschweig, Germany.
I KolleckerInstitute of Pathology, Academic Hospital Braunschweig, Braunschweig, Germany.
P PetersenInstitute of Special Pharmacotherapy, Helios-Clinic of Oncology, Duisburg, Germany.
N GaßlerInstitute of Pathology, Academic Hospital Braunschweig, Braunschweig, Germany.
J WolfProfessional Trade Association for Wood and Metal, Munich, Germany.
H-G SchroederENT-Clinic, Academic Hospital Braunschweig, Braunschweig, Germany. hageschroeder@gmail.com.
Klinikum Braunschweig · DEHelios Kliniken · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical and histological parameters from 117 patients with wood dust-related sinonasal adenocarcinomas of intestinal type (ITAC) were analyzed and correlated with a follow-up period of 5 years at least. The rate of survival for 5 years was 53.1 % and for 10 years 30.2 %. Only 33 patients were free of disease. 74.2 % of patients with recurrences died in relation to ITAC. As expected, tumors of T4-category had the worst prognosis. The mucus content of a tumor was the most important histological parameter. Endonasal methods of surgery had no more positive survival rates after 5 years. An effect of radiotherapy has to be in discussion. The high incidence of tumor recurrences requires control examinations consistently.

Indexed as

DustAdenocarcinomaAdultAgedAged, 80 and overFemaleGermanyHumansMaleMiddle AgedNeoplasm Recurrence, LocalNose NeoplasmsOccupational DiseasesOccupational ExposureParanasal Sinus NeoplasmsPrognosisDustFollow-upPrognostic factorRadiotherapySinonasal adenocarcinomaWood dust

Identifiers

PMID27040559
OpenAlexW2317887530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.